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Purpose: To assess the state and dynamics of the intracranial system in idiopathic 
normal-pressure hydrocephalus (I-NPH), we determined intracranial compliance 
using magnetic resonance imaging (MRI). 
Materials and Methods: The intracranial compliance index (ICCI), which was 
defined as the ratio of the peak-to-peak intracranial volume change (ICVCp-p) to 
the peak-to-peak CSF pressure gradient (PGp-p) during the cardiac cycle, was 
obtained from the net transcranial blood and CSF flow measured with 
phase-contrast cine MRI. ICCI was determined in patients with I-NPH (n=7), 
brain atrophy or asymptomatic ventricular dilation (VD, n=6), and in healthy 
volunteers (control group; n=11). The changes in ICCI indices were also analyzed 
after a CSF tap test (n=2).  
Results: The ICCI in the I-NPH group was significantly lower than in the control 
and VD groups, whereas no difference was found between the control and VD 
groups. The ICVCp-p was also lower than in the control and VD groups. However, 
no significant difference was found in the PGp-p between groups. The ICCI 





Conclusion: intracranial compliance analysis with MRI makes it possible to 
noninvasively obtain more detailed information of intracranial biomechanics in 
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For diagnosing a normal-pressure hydrocephalus (NPH), clinical symptoms (gait 
disturbance, dementia, and incontinence) and their follow-up observations are 
crucial, but there are still many unsolved problems with this syndrome in terms of 
the diagnostic criteria and selection of appropriate patients for shunt surgery (1). 
In particular, diagnosis of idiopathic NPH (I-NPH) without a known cause of 
communicating hydrocephalus is more difficult (2-6) than that of secondary NPH 
with evidence of previous subarachnoid haemorrhage, meningitis, head injury, or 
numerous other conditions. Therefore, cerebrospinal fluid (CSF) flow studies with 
magnetic resonance imaging (MRI) (7-11) and some invasive examinations (2-6) 
such as tap test or CSF outflow resistance via an infusion test have been 
performed in addition to clinical findings and conventional image diagnosis with 
X-ray computed tomography or MRI. The MRI CSF flow studies (e.g., analysis of 
CSF flow velocity or volumetric flow rate in the aqueduct) noninvasively 
obtained information about changes in intracranial mechanical properties, i.e., 
intracranial compliance (defined as the ratio of intracranial volume change to 





there is a limitation that the CSF flowmetry does not always show changes in 
intracranial compliance because CSF flow is modulated by the hemodynamics of 
the brain (14). Therefore, in the present study, we directly analyzed the 
intracranial compliance in I-NPH using cine-MRI to noninvasively assess the state 
and dynamics of the intracranial system and to assist in diagnosis. The intracranial 
compliance index (ICCI) was calculated with change of volume loading to the 
cranium, i.e., net intracranial volume change, and CSF pressure gradient during 
the cardiac cycle, based on the MR-ICP method of Alperin et al (15). We describe 
the characteristics of the ICCI in I-NPH, and the usefulness of its analysis. 
 
 
MATERIALS AND METHODS 
ICCI Determination  
The ICCI, which is defined as the ratio of the maximal intracranial volume change 
to the maximal craniospinal CSF pressure gradient change during the cardiac 
cycle, was obtained from the net transcranial blood flow, CSF flow, and 





of these measurements, the reader is referred to reference 15. In short (flow chart 
in Fig. 1), we first set the vertical slice plane at the mid-C2 level against the 
cerebrospinal axis (Fig. 1a-c), and twice obtained velocity-mapped phase images 
with different velocity encoding gradients for CSF flow and cord displacement as 
well as for transcranial blood flow, respectively (Fig. 1d and e). 
  To obtain the net transcranial flow, we measured the flow or displacement 
during the cardiac cycle in each region; CSF flow [Vc(t)], displacement of cord 
[Vs(t)], arterial inflow (the sum of both internal carotid arteries and both vertebral 
arteries) [Va(t)], and venous outflow (the sum of both internal jugular veins) 
[Vv(t)] (Fig. 1d and e). At this time, we corrected the baseline offset due to eddy 
currents by a subtraction process (14). After venous outflow was scaled up so that 
mean intracranial volume change was zero (14-16), and the intracranial volume 
change was obtained from following Equation: 
ICVC(t) = Va (t) + Vv (t) + Vc (t) + Vs(t)[ ]dt∫ ,                   ---(1) 
where the measured volumetric flow in each region was positive in the cranial 
direction. 





cycle, which was calculated from the above measured CSF flow velocity using a 
following simplified Navier-Stokes Equation (17): 










⎠ ⎟ ,                           ---(2) 
where x, y, and z are coordinates, and z-direction is a canal axis. P and w are the 
pressure and the axial velocity, and ρ and μ are the fluid density (CSF: 
1.0007 g/cm3) and viscosity (CSF: 1.1 cP), respectively. Then the CSF pressure 
gradient was normalized by multiplying the CSF flow area (15). 
  Finally, the ICCI was obtained by dividing the peak-to-peak normalized CSF 
pressure gradient change (PGp-p) into the peak-to-peak intracranial volume change 
(ICVCp-p) during the cardiac cycle. 
 
Study Subjects 
ICCI analysis was performed in patients with I-NPH (four men and three women, 
73±7 years) and asymptomatic ventricular dilation or brain atrophy (VD; three 
men and three women, 79±3 years), and in healthy volunteers (control group; 
nine men and two women, 36±13 years). All patients with I-NPH showed 





and removal of CSF (30 mL or CSF pressure fell to zero). In two cases of I-NPH, 
the ICCI, ICVCp-p, and PGp-p were compared before and after the tap test. The rate 
(R) of change was calculated by 
R (%) = 100 (Sa-Sb) / Sb ,                                     --- (3)   
where Sb and Sa indicate each value before and after tap test. 
 The purpose and procedures of all our investigations were fully explained to all 
patients, and the studies were performed only after obtaining informed consent 
from each patient. The Mann-Whitney U test was used to determine the 
significance between the groups. 
 
Imaging Conditions 
Measurements were done using retrospective cardiac gated PC cine-MRI on a 1.5 
T MR system (Gyroscan Intera; Philips Medical Systems International, Best, The 
Netherlands), and 32-phase images were obtained in a cardiac cycle. A gradient 
echo pulse sequence (T1-FFE) was used with shortest echo time, flip angle of 25 
degrees (for CSF flow and cord displacement) and 20 degrees (for blood flow), 





140×140 mm rectangular field of view, and 256×128 acquisition matrix. The 
raw data matrix was zero padded to 512×512 to easily trace the contour of each 
region. Velocity encoded gradient was set at 7 cm/s for CSF flow and cord 
displacement and at 80 cm/s for blood flow along the cranio-caudal axis, 
respectively. The precision flow measurements under these imaging conditions 
correspond very well with the measured values obtained using an electromagnetic 




The average ICCI of I-NPH group was 4.99 mL/[Pa•m] (SD = 1.88) compared 
with 11.4 mL/[Pa•m] (SD = 7.27) for control group and 20.5 mL/[Pa•m] (SD = 
20.6) for VD group (Fig. 2). The ICCI in the I-NPH group was significantly lower 
than in the control and VD groups (P values were 0.03 and 0.01, respectively), 
whereas there was no significant difference in the ICCI between the VD and 
control groups (P = 0.42) (Fig. 2).  





SD, 0.422 ± 0.190 mL) than in the control (0.856 ± 0.375 mL) and VD groups 
(1.32 ± 1.20 mL) (P values were 0.01 and 0.03, respectively), but there was no 
significant difference (P = 0.76) in the ICVCp-p between the VD and control 
groups (Fig. 3).  
 On the other hand, the average PGp-p was not significantly different in the I-NPH 
group (mean ± SD, 0.0837 ± 0.0162 Pa•m) from the control (0.0869 ± 0.0301 
Pa•m) and VD groups (0.0743 ± 0.0390 Pa•m) (P values were 0.86 and 0.67, 
respectively), and there was no significant difference (P = 0.58) in the PGp-p 
between the VD and control groups (Fig. 4). 
 ICCI values in both I-NPH patients after the tap test were greater than those 
before (Fig. 5). In one patient the increase of ICCI (case A in Fig. 5) was the result 
of increase in ICVCp-p and decrease in PGp-p values after tap test. In another 









Since the diagnosis and management of I-NPH remains unclear as compared to 
the secondary NPH, numerous techniques are used to identify patients who are 
likely to have I-NPH, and various means are used to identify those patients most 
likely to respond to treatment (6). In particular, CSF tap test or CSF outflow 
resistance via an infusion test is one of the reliable examinations (6), but these are 
invasive. It has been reported that a single standard for the prognostic evaluation 
of I-NPH patients was lacking, and that supplemental tests could increase the 
predictive accuracy of the prognosis (6). Therefore, we attempted intracranial 
compliance analysis using MRI as a noninvasive examination. Various reports 
have indicated that the compliance in patients with NPH declined (8, 10-13). In 
fact, we recently verified that there is a positive correlation between the ICCI and 
the pressure-volume response determined by the ICP changes after a bolus 
injection of saline (1-5 ml) into the lateral ventricle, as an invasive measure of 
compliance (19). When it is difficult to differentiate VD from NPH on ordinary 
MRI or X-ray CT, the ICCI analysis with MRI will likely prove useful.  
 In our ICCI studies, the ages between the I-NPH group and control group were 





low negative slope of compliance/age has been reported (20). In fact, there was no 
significant correlation between ICCI and age (R2=0.31, P>0.05). This is because 
the change with age may be included in the determination error such as a 
reproducibility of ICCI within 20%. Therefore, we took alterations in ICCI 
induced by age differences as being negligible compared with the large changes 
by I-NPH (11). 
 On the other hand, the fact that ICVCp-p in I-NPH was also significantly smaller 
(Fig. 3) coincided with a recent result (21) indicating that patients with Chiari 
malformation have low compliance．Our result also can be explained by a theory, 
according to which, due to the reduced compliance of the intracranial 
compartment, venous and CSF outflow occur more immediately following the 
systolic increase in arterial blood inflow, which in turn results in a smaller systolic 
increase in intracranial volume, i.e., ICVCp-p (21)．This ICVCp-p change provides 
additional diagnostic information on I-NPH. Moreover, the fact that PGp-p in 
I-NPH did not significantly change in other groups (Fig. 4) would indicate the 






 The increase in ICCIs of both I-NPH patients with positive CSF tap test (Fig. 5) 
can be explained by an increase in compliance by withdrawing CSF．However, the 
reason for the ICCI increase is not the same; in one case, ICVCp-p increased 
because PGp-p decreased. In another case, it was due to the fact that mainly the 
ICVCp-p increased. The exact reason must be pursued in detail in forthcoming 
studies of a larger sample. 
 In conclusion, we investigated intracranial compliance using MRI in I-NPH 
patients and compared with VD and healthy subjects. The ICCI and ICVCp-p in the 
I-NPH group were significantly lower than in the control and VD group, but there 
was no significant difference between the VD and control groups. There was no 
significant difference in the PGp-p between groups. ICCI in I-NPH increased after 
the CSF tap test. ICCI analysis using PC cine MRI makes it possible to 
noninvasively obtain a more detailed determination of the intracranial state in 
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Figure 1.  Procedure (upper flow chart), and (a-c) slice and ROI position for 
obtaining intracranial compliance index (ICCI). (a) T1-weighted image in the 
mid-sagittal plane and (b, c) thickened phase-contrast (PC) MR angiograms on 
right and left sides for setting the slice plane (dotted line). (d) Velocity-mapped 
PC cine MRI for determining the CSF flow (†) and spinal cord displacement (＊). 
(e) Velocity-mapped PC cine MRI for arterial inflow, i.e., right and left internal 
carotid arteries (1 and 2) and vertebral arteries (3 and 4), and venous outflow, i.e., 
both internal jugular veins (5 and 6). 
 
Figure 2.  Intracranial compliance indices (ICCI) obtained with MRI in patients 
with idiopathic normal-pressure hydrocephalus (I-NPH) and asymptomatic 
ventricular dilation or brain atrophy (VD), and in healthy volunteers (control). 
Data are shown as mean ± SD. Asterisks indicate significantly different values 
between these groups (P<0.05). NS: not significant. 
 
Figure 3.  Peak-to-peak intracranial volume changes (ICVCp-p, means ± SDs) 
determined with MRI in each group. Asterisks indicate significantly different 
values between these groups (P<0.05). NS: not significant. 
 
Figure 4.  Peak-to-peak normalized pressure gradients (PGp-p, means ± SDs) 
calculated with MRI in each group. NS: not significant. 
 
Figure 5.  The changing rates of each of the intracranial volume change 
(ICVCp-p), peak-to-peak normalized pressure gradient (PGp-p), and intracranial 






・Twice obtained axial velocity-mapped images in each cardiac
phase at the C2 level (dotted line in a-c).
1st  : ±80 cm/s velocity encoding for blood flow
2nd : ±7 cm/s velocity encoding for CSF flow and cord
2. Flow and displacement determination
・Flow and motion measurements in each ROI, and correction.
Arterial inflow (1-4 in e), venous outflow (5 and 6 in e), and
displacement of cord (* in d) and CSF flow († in d) . 
3. Calculation of intracranial volume change (ICVC)
・From the net transcranial flow during the cardiac cycle 
4. Calculation of CSF pressure gradient (PG)     
・Using a simplified Navier-Stokes Equation and
normalizing by the CSF flow area († in d ).  
Peak-to-peak ICVC
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